Eyenovia is a biopharmaceutical company that provides a portfolio of next generation topical eye treatments.
Eyenovia has raised $10.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in May 2026.
Eyenovia's investors include Avenue Capital Group, Armistice Capital, Silicon Valley Bank.
Eyenovia is headquartered in New York, United States.
Eyenovia is a biopharmaceutical company that provides a portfolio of next generation topical eye treatments.
Eyenovia is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Eyenovia — Funding & Investors." VCBacked, May 6, 2026, https://www.vcbacked.co/company/eyenovia. Accessed October 10, 2026.
VCBacked. (2026). Eyenovia — Funding & Investors. Retrieved October 10, 2026, from https://www.vcbacked.co/company/eyenovia
{{cite web |title=Eyenovia — Funding & Investors |url=https://www.vcbacked.co/company/eyenovia |website=VCBacked |access-date=October 10, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated